Transvaginal natural orifice endoscopic surgery for extremely obese patients with early‐stage endometrial cancer

Abstract Aim The purpose of this study was to assess the feasibility and efficacy of transvaginal natural orifice transluminal endoscopic surgery (v‐NOTES) staging surgery for extreme obese patients with early‐stage type‐1 endometrial cancer. Methods Study included cases of extreme obese patients with early‐stage endometrial cancer who underwent v‐NOTES between January 2019 and June 2019 at a tertiary referral medical center. The following parameters were noted: patient age, body mass index (BMI), operating time, conversion to conventional laparoscopy or laparotomy, any intraoperative or postoperative complications, estimated blood loss, pre‐ and postoperative hemoglobin levels, postoperative pain scores of the patients using visual analogue scale (VAS) at 6th, 12th and 24th h, length of hospital stay and final pathology report. Results Six cases of extreme obese patients with early‐stage endometrial cancer underwent hysterectomy and bilateral salpingo‐oophorectomy via the transvaginal NOTES. These six patients had a mean body mass index of 51.4 kg/m 2 (SD = 6,13). No conversion to conventional laparoscopy or even laparotomy was needed in any of these patients. No adjuvant therapy was needed since all of the patients had early‐stage endometrial carcinoma. Conclusion Given the increased risk of surgical morbidity and mortality associated with increasing BMI, it is paramount importance to establish safe surgical approaches to gynecological pathologies. We think that v‐NOTES offers greater benefit to obese patients when performed by an experienced surgeon and v‐NOTES is a safe, effective and feasible minimally invasive surgery in extreme obese patients with early endometrial cancer.